Martelli, Alberto M.

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 5,894

Targeting GSK3 and Associated Signaling Pathways Involved in Cancer

Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Martelli, A. M., Cocco, L., Ratti, S., Candido, S., Libra, M., Montalto, G., et al. (2020) · Cells

Wnt/β-catenin signaling in development and cancerPI3K/AKT/mTOR signaling in cancer

Cited by 284

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

McCubrey, J. A., Yang, L. V., Abrams, S. L., Steelman, L. S., Follo, M. Y., Cocco, L., Ratti, S., Martelli, A. M., Augello, G., & Cervello, M. (2022) · Cells

Pancreatic and Hepatic Oncology ResearchMicroRNA in disease regulation

Cited by 49

PKR Regulates B56α-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells

Ruvolo, V. R., Kurinna, S. M., Karanjeet, K. B., Schuster, T. F., Martelli, A. M., McCubrey, J. A., & Ruvolo, P. P. (2008) · Journal of Biological Chemistry

Cell death mechanisms and regulationProtein Kinase Regulation and GTPase Signaling

Cited by 48

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals

Abrams, S. L., Lertpiriyapong, K., Yang, L. V., Martelli, A. M., Cocco, L., Ratti, S., Falasca, M., Murata, R. M., Rosalen, P. L., Lombardi, P., et al. (2018) · Advances in Biological Regulation

Pancreatic and Hepatic Oncology ResearchCancer-related Molecular Pathways

Cited by 36

Protective Effect of Different Antioxidant Agents in UVB-Irradiated Keratinocytes

Salucci, S., Burattini, S., Buontempo, F., Martelli, A. M., Falcieri, E., & Battistelli, M. (2017) · European Journal of Histochemistry

Skin Protection and AgingPhytochemicals and Antioxidant Activities

Cited by 32

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

McCubrey, J. A., Meher, A. K., Akula, S. M., Abrams, S. L., Steelman, L. S., LaHair, M. M., Franklin, R. A., Martelli, A. M., Ratti, S., Cocco, L., et al. (2022) · Aging

Cancer-related Molecular PathwaysPancreatic and Hepatic Oncology Research

Cited by 12